Kinetics of metabolism of deltamethrin and cis- and trans-permethrin in vitro. Studies using rat and human liver microsomes, isolated rat hepatocytes and rat liver cytosol

References

• Anand SS, Bruckner JV, Haines WT, et al. (2006a). Characterization of deltamethrin metabolism by rat plasma and liver microsomes. Toxicol Appl Pharmacol 212:156–66.
   PubMed Web of Science ®Google Scholar
• Anand SS, Kim K-B, Padilla S, et al. (2006b). Ontogeny of hepatic and plasma metabolism of deltamethrin in vitro: role in age-dependent acute neurotoxicity. Drug Metab Dispos 34:389–97.
   PubMed Web of Science ®Google Scholar
• Austin RP, Barton P, Cockroft SL, et al. (2002). The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties. Drug Metab Dispos 30:1497–503.
   PubMed Web of Science ®Google Scholar
• Bhat BK. (1995). Breeding methodologies applicable to pyrethrum. In: Casida JE and Quistad GB, eds. Pyrethrum flowers: production, chemistry, toxicology, and uses. New York: Oxford University Press, 67–94.
   Google Scholar
• Crow JA, Borazjani A, Potter PM, Ross MK. (2007). Hydrolysis of pyrethroids by human and rat tissues: examination of intestinal, liver and serum carboxylesterases. Toxicol Appl Pharmacol 221:1–12.
   PubMed Web of Science ®Google Scholar
• Elliott M. (1995). Chemicals in insect control. In: Casida JE and Quistad GB, eds. Pyrethrum flowers: production, chemistry, toxicology, and uses. New York: Oxford University Press, 3–31.
   Google Scholar
• Gammon DW, Chandrasekaran A, Elnaggar SF. (2012). Comparative metabolism and toxicology of pyrethroids in mammals. In: Marrs TC, ed. Issues in toxicology no 12, mammalian toxicology of insecticides. Cambridge, UK: RSC Publishing, 137–183.
   Google Scholar
• Gertz M, Kilford PJ, Houston JB, Galetin A. (2008). Drug lipophilicity and microsomal protein concentration as determinants in the prediction of the fraction unbound in microsomal incubations. Drug Metab Dispos 36:535–42.
   PubMed Web of Science ®Google Scholar
• Godin SJ, Crow JA, Scollon EJ, et al. (2007). Identification of rat and human cytochrome p450 isoforms and a rat serum esterase that metabolize the pyrethroid insecticides deltamethrin and esfenvalerate. Drug Metab Dispos 35:1664–71.
   PubMed Web of Science ®Google Scholar
• Godin J, DeVito MJ, Hughes MF, et al. (2010). Physiologically based pharmacokinetic modeling of deltamethrin: development of a rat and human diffusion-limited model. Toxicol Sci 115:330–43.
   PubMed Web of Science ®Google Scholar
• Godin SJ, Scollon EJ, Hughes MF, et al. (2006). Species differences in the in vitro metabolism of deltamethrin and esfenvalerate: differential oxidative and hydrolytic metabolism by humans and rats. Drug Metab Dispos 34:1764–71.
   PubMed Web of Science ®Google Scholar
• Hallifax D, Houston JB. (2006). Binding of drugs to hepatic microsomes: comment and assessment of current prediction methodology with recommendation for improvement. Drug Metab Dispos 34:724–6.
   PubMed Web of Science ®Google Scholar
• Hedges L, Brown S, Vardy A, et al. (2019). Metabolism of deltamethrin and cis- and trans-permethrin by rat and human liver microsomes, liver cytosol and plasma preparations. Xenobiotica 49:388–96.
   PubMed Web of Science ®Google Scholar
• Houston JB, Galetin A. (2008). Methods for predicting in vivo pharmacokinetics using data from in vitro assays. Curr Drug Metab 9:940–51.
   PubMed Web of Science ®Google Scholar
• Jones HM, Houston JB. (2004). Substrate depletion approach for determining in vitro metabolic clearance: time dependencies in hepatocyte and microsomal incubations. Drug Metab Dispos 32:973–82.
   PubMed Web of Science ®Google Scholar
• Kalvass JC, Tess DA, Giragossian C, et al. (2001). Influence of microsomal concentration on apparent intrinsic clearance: implications for scaling in vitro data. Drug Metab Dispos 29:1332–6.
   PubMed Web of Science ®Google Scholar
• Kaneko H. (2011). Pyrethroids: mammalian metabolism and toxicity. J Agric Food Chem 59:2786–91.
   PubMed Web of Science ®Google Scholar
• Kilford PJ, Gertz M, Houston JB, Galetin A. (2008). Hepatocellular binding of drugs: correction for unbound fraction in hepatocyte incubations using microsomal binding or drug lipophilicity data. Drug Metab Dispos 36:1194–7.
   PubMed Web of Science ®Google Scholar
• Lake BG. (1987). Preparation and characterisation of microsomal fractions for studies of xenobiotic metabolism. In: Snell K and Mullock, B, eds. Biochemical toxicology: a practical approach. Oxford: IRL Press, 183−215.
   Google Scholar
• Laskowski DA. (2002). Physical and chemical properties of pyrethroids. Rev Environ Contam Toxicol 174:49–170.
   PubMedGoogle Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–75.
   PubMed Web of Science ®Google Scholar
• Mirfazaelian A, Kim K-B, Anand SS, et al. (2006). Development of a physiologically based pharmacokinetic model for deltamethrin in the adult male Sprague-Dawley rat. Toxicol Sci 93:432–42.
   PubMed Web of Science ®Google Scholar
• Nallani GC, Chandrasekaran A, Kassahun K, et al. (2018). Age dependent in vitro metabolism of bifenthrin in rat and human hepatic microsomes. Toxicol Appl Pharmacol 338:65–72.
   PubMed Web of Science ®Google Scholar
• Obach RS. (1997). Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol. Drug Metab Dispos 25:1359–69.
   PubMed Web of Science ®Google Scholar
• Obach RS. (1999). Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes. Drug Metab Dispos 27:1350–9.
   PubMed Web of Science ®Google Scholar
• Parker AJ, Houston JB. (2008). Rate-limiting steps in hepatic drug clearance: comparison of hepatocellular uptake and metabolism with microsomal metabolism of saquinavir, nelfinavir, and ritonavir. Drug Metab Dispos 36:1375–84.
   PubMed Web of Science ®Google Scholar
• Ross MK, Borazjani A, Edwards CC, Potter PM. (2006). Hydrolytic metabolism of pyrethroids by human and other mammalian carboxylesterases. Biochem Pharmacol 71:657–69.
   PubMed Web of Science ®Google Scholar
• Scollon EJ, Starr JM, Godin SJ, et al. (2009). In vitro metabolism of pyrethroid pesticides by rat and human hepatic microsomes and cytochrome P450 isoforms. Drug Metab Dispos 37:221–8.
   PubMed Web of Science ®Google Scholar
• Soderlund DM. (2012). Molecular mechanisms of pyrethroid insecticide neurotoxicity: recent advances. Arch Toxicol 86:165–81.
   PubMed Web of Science ®Google Scholar
• Soderlund DM, Clark JM, Sheets LP, et al. (2002). Mechanisms of pyrethroid neurotoxicity: implications for cumulative risk assessment. Toxicology 171:3–59.
   PubMed Web of Science ®Google Scholar
• Song G, Moreau M, Efremenko A, et al. (2019). Evaluation of age-related pyrethroid pharmacokinetic differences in rats: physiologically-based pharmacokinetic model development using in vitro data and in vitro to in vivo extrapolation. Toxicol Sci 169:365–79.
   PubMed Web of Science ®Google Scholar
• Stringer RA, Strain-Damerell C, Nicklin P, Houston JB. (2009). Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions. Drug Metab Dispos 37:1025–34.
   PubMed Web of Science ®Google Scholar
• Tornero-Velez R, Mirfazaelian A, Kim K-B, et al. (2010). Evaluation of deltamethrin kinetics and dosimetry in the maturing rat using a PBPK model. Toxicol Appl Pharmacol 244:208–17.
   PubMed Web of Science ®Google Scholar
• Yabe Y, Galetin A, Houston JB. (2011). Kinetic characterization of rat hepatic uptake of 16 actively transported drugs. Drug Metab Dispos 39:1808–14.
   PubMed Web of Science ®Google Scholar
• Yang D, Wang X, Chen Y-T, et al. (2009a). Pyrethroid insecticides: isoform-dependent hydrolysis, induction of cytochrome P450 3A4 and evidence on the involvement of the pregnane X receptor. Toxicol Appl Pharmacol 237:49–58.
   PubMed Web of Science ®Google Scholar
• Yang D, Pearce RE, Wang X, et al. (2009b). Human carboxylesterases HCE1 and HCE2: ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrin. Biochem Pharmacol 77:238–47.
   PubMed Web of Science ®Google Scholar